Skip to main content

Hearing Screening Diagnostic Devices Market Report 2019 on Comprehensive Research by Key Dynamics



Hearing Screening Diagnostic Devices Market 2020 Global Trend Analysis by Product (OAE/ABR Testing Devices, Audiometers, Immittance Screeners), Age (Newborn Hearing Screening, Others), Indication (Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss), Test (Pure-tone Test, Bone Conduction Test), End-user (Hospital & Clinics, Diagnostic Centers), and Regional Industry Forecast to 2023.

global hearing screening diagnostic devices market Growth would witness a peak in valuation with Rising CAGR of 6.50% during the forecast period, 2018-2023.

Hearing Screening Diagnostic Devices Market Key Players
The leading players contributing in the hearing screening diagnostic devices market include
Natus Medical Incorporated
Inventis srl
Accent Hearing Pty Ltd
Otodynamics Ltd.
Amplivox Limited
IntriCon Corporation
Sivantos Pte. Ltd
MAICO Diagnostics GmbH
Otometrics
Starkey
Intelligent Hearing Systems
and Others.
Growth and Restraints Factors of Global Market
The growing geriatric population, high noise levels that cause deafness, and genetic complications are factors that can stimulate market demand during the forecast period. The high birth rate in developing countries has led to concerns among newborns who develop hearing loss.
Demand for advanced screening procedures to detect this at an early stage and take corrective action is one of the market drivers for hearing diagnostic devices. Country initiatives to launch early hearing detection and intervention programs to raise public awareness should have a positive impact on the market.
The market for hearing diagnostic equipment will gain strength as the number of hearing disorders increases. The high demand for screening procedures to detect these disorders in a preventive phase is likely to boost the market. A high level of noise nuisance created in manufacturing industries that cause deafening in some cases is expected to induce market demand.
The underdeveloped health sector in Africa can be a lucrative opportunity for market participants to expand their reach. Improving the health budgets of emerging and developed economies can be useful for the development of research in advanced screening tests.
Regional Outlook
The Americas is predicted to dominate the market due to a large number of patients, the plethora of diagnostic tools for large scale testing, and rising healthcare costs. On the other hand, the market for APAC hearing screening hearing diagnosis equipment is set to grow exceptionally, thanks to improvements in healthcare infrastructure and the large patient pool in developing economies. In addition, the regions of Europe and MEA are expected to record modest growth rates.
Hearing Screening Diagnostic Devices Market Segmentation
The market is diversified on the basis of product in (OAE)/auditory brainstem response (ABR) testing devices, immittance screeners, and audiometers. The audiometers are divided into diagnostic and screening audiometers. The OAE/ABR test equipment segment represented 67% of the market in 2017, followed by audiometers, immittance control systems, and others.
Based on age, it is segregated into neonatal hearing screening and others. It could reach $623.53 million in 2023, which can be attributed to hearing loss in newborns and premature babies.
The global market based on indication is bifurcated into conductive hearing loss, combined hearing loss, sensorineural hearing loss, and others. The sensorineural segment is expected to be the second-largest profitable segment. generates.
The test segment is broadly classified into speech discrimination test, bone conduction test, pure tone test, middle ear test, speech recognition threshold test, more comfortable hearing test, and uncomfortable volume level test.
Moreover, the hearing screening diagnostics market is further broadly divided into hospitals and clinics, diagnostic centers, and so on. Hospitals and clinics are expected to generate significant revenues in the global market by 2023 due to their ability to manage large numbers of patients. Diagnostic centers held the second largest market share due to the latest equipment available to perform hearing screening procedures.
include hospitals & clinics, diagnostic centers, and others. Hospitals and clinics are likely to generate high revenue for the global market till 2023 owing to its capability to handle high patient volume. Diagnostic centers accounted for the second-highest market share owing to the latest equipment available for conducting hearing screening procedures.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more